Here, we present the first case in the literature reporting lactic acidosis due to venlafaxine overuse in an adolescent.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Eldem İ, Kendirli T, Azapağası E, Özdemir G, Yıldız Ç, Yılmaz MM, Karataşoğlu Ö, Benderlioğlu E.
📊
Key Findings & Data:Turk J Pediatr 2016; 58: 200-202.Venlafaxine is a selective serotonin noradrenaline reuptake inhibitor and commonly prescribed antidepressant in adults.
💡
Conclusion & Impact:Here, we present the first case in the literature reporting lactic acidosis due to venlafaxine overuse in an adolescent.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters
Abstract
Eldem İ, Kendirli T, Azapağası E, Özdemir G, Yıldız Ç, Yılmaz MM, Karataşoğlu Ö, Benderlioğlu E. Venlafaxine intoxication in an adolescent presenting with severe lactic acidosis. Turk J Pediatr 2016; 58: 200-202.Venlafaxine is a selective serotonin noradrenaline reuptake inhibitor and commonly prescribed antidepressant in adults. Most patients overdosing with venlafaxine develop only mild symptoms. Severe toxicity is reported with the most common symptoms being CNS depression, serotonin toxicity, seizure, or cardiac conduction abnormalities. However, lactic acidosis is an uncommon adverse effect. Here, we present the first case in the literature reporting lactic acidosis due to venlafaxine overuse in an adolescent.
🔖
Cite This Article
KENDİRLİ, T., AZAPAĞASI, E., BENDERLİOĞLU, E., ÖZDEMİR, G., YILMAZ, M. M., YILDIZ, Ç., KARATAŞOĞLU, Ö., ELDEM, İ. (2022). Venlafaxine intoxication in an adolescent presenting with severe lactic acidosis. Turkish Journal of Pediatrics, Cilt: 58 - Sayı: 2, 200–202. https://ajindex.com/articles/613214
Hawton K, Bergen H, Simkin S, et al. Toxicity of antidepressants: rates of suicide relative to prescribing and nonfatal overdose. Br J Psychiatry 2010; 196: 354- 358
Weller EB, Weller RA, Davis GP. Use of venlafaxine in children and adolescents: a review of current literature. Depress Anxiety 2000; 12(Suppl 1): 85-89
Iragavarapu C, Gupta T, Chugh SS, Aronow WS, Frishman WH. Type B lactic acidosis associated with venlafaxine overdose. Am J Ther 2016; 23: e1082-e1084
Kent JM. SNaRIs, NaSSAs, and NaRIs: New agents for the treatment of depression. Lancet 2000; 355: 911-918
Taurines R, Gerlach M, Warnke A, Thome J, Wewetzer C. Pharmacotherapy in depressed children and adolescents. World J Biol Psychiatry 2011; 12 (Suppl 1): 11-15
Francino MC, Deguigne MB, Badin J, Turcant A, Perrotin D. Hypoglycemia: a little known effect of Venlafaxine overdose. Clin Toxicol (Phıla) 2012; 50: 215-217
Hanekamp BB, Zijlstra JG, Tulleken JE, Ligtenberg JJ, van der Werf TS, Hofstra LS. Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report. Neth J Med 2005; 63: 316-318
Fischer M, Untrecker S, Pfuhlmann B. Overdose of venlafaxine with mild outcome. Neuroscience & Medicine 2012; 3: 327-329
Woodhouse B, Erramouspe J. Accidental ingestion of venlafaxine in a 9 month old infant. The Internet Journal of Toxicology 2012; 8: 1-4
Kraut JA, Madias NE. Lactic Acidosis. N Engl J Med 2014; 371: 2309-2319
Murphy ND, Kodakat SK, Wendon JA, et al. Liver and intestinal lactate metabolism in patients with acute hepatic failure undergoing liver transplantation. Crit Care Med 2001; 29: 2111-2118
Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000; 348: 607-614.